Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053357

Director bought 30,000 shares at $1.29 ($38,700)

From the SEC's structured data for this filing

Trades in this filing

Sukhtian Faisal Ghiath · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-10-07 Purchase : show line 1 in the form +30,000 $1.29 $38,700 68,000 D
Open-market purchases · 30,000 sh · avg $1.29 · $38,700
Loading xslF345X03/doc4.xml…